ALLE
37
5
HPE
55
11
WAT
47
5
VFC
47
-5
HRB
51
2
COF
55
-3
IPG
49
10
UNH
61
6
EIX
77
2
WMT
74
2
FDX
36
-4
HP
38
-2
WDC
41
-2
CSCO
63
2
DD
56
3
USB
50
2
VRSN
53
3
PCG
93
2
JWN
40
-2
EXC
54
-2
ALLE
37
5
HPE
55
11
WAT
47
5
VFC
47
-5
HRB
51
2
COF
55
-3
IPG
49
10
UNH
61
6
EIX
77
2
WMT
74
2
FDX
36
-4
HP
38
-2
WDC
41
-2
CSCO
63
2
DD
56
3
USB
50
2
VRSN
53
3
PCG
93
2
JWN
40
-2
EXC
54
-2
Financhill
Back

Palatin Technologies Vs. Theriva Biologics Industry Stock Comparison

Sell
40

PTN
Palatin Technologies

Last Price:
0.91
Seasonality Move:
16.84%
Sell
42

TOVX
Theriva Biologics

Last Price:
1.28
Seasonality Move:
98.81%
Sell
40
Palatin Technologies (PTN) is a Sell

Is Palatin Technologies a Buy, Sell or Hold?

  • The current Palatin Technologies [PTN] share price is $0.91. The Score for PTN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • PTN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Theriva Biologics (TOVX) is a Sell

Is Theriva Biologics a Buy, Sell or Hold?

  • The current Theriva Biologics [TOVX] share price is $1.26. The Score for TOVX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • TOVX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTN Stock Price Chart

What is Palatin Technologies's stock price today?

  • The Palatin Technologies share price today is $0.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTN is experiencing selling pressure, which indicates risk of future bearish movement.

TOVX Stock Price Chart

What is Theriva Biologics's stock price today?

  • The Theriva Biologics share price today is $1.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TOVX is experiencing selling pressure, which indicates risk of future bearish movement.

PTN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 37.31 Sell
Chaikin Money Flow: -68171 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1 - 1.22) Sell
Bollinger Bands (100): (1.02 - 1.64) Sell

TOVX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 35.64 Sell
Chaikin Money Flow: -40489 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.32 - 1.86) Sell
Bollinger Bands (100): (1.67 - 5.69) Sell

PTN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.05 Sell
20-day SMA: 1.13 Sell
50-day SMA: 1.07 Sell
200-day SMA: 1.73 Sell
8-day EMA: 1.02 Sell
20-day EMA: 1.07 Sell
50-day EMA: 1.14 Sell
200-day EMA: 1.66 Sell

TOVX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.4 Sell
20-day SMA: 1.61 Sell
50-day SMA: 2.03 Sell
200-day SMA: 6.83 Sell
8-day EMA: 1.4 Sell
20-day EMA: 1.58 Sell
50-day EMA: 2.21 Sell
200-day EMA: 6.25 Sell

Palatin Technologies Earnings Growth & PTN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and an increase next year of $0.85 per share.

Theriva Biologics Earnings Growth & TOVX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.00 per share, and an increase next year of $22.60 per share.

Palatin Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Theriva Biologics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):